InterCure Ltd. Form 6-K Summary
Business Context and Reporting Period
InterCure Ltd., an Israeli foreign private issuer, filed a Form 6-K for July 2022 on July 15, 2022. The filing announces and furnishes the notice of the company’s annual and special meeting of shareholders, scheduled for September 15, 2022.
Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes Versus Prior Period
The filing does not report financial or operating changes versus a prior comparable period. Its substantive disclosure is the shareholder-meeting notice.
Guidance, Outlook, Risks, and Unusual Items
The filing does not provide management guidance, outlook commentary, risk updates, contingencies, or unusual financial items.
Important Facts to Verify
- Review Exhibit 99.1, the Notice of Annual and Special Meeting of Shareholders dated July 15, 2022.
- Confirm the meeting date of September 15, 2022 and the matters submitted for shareholder consideration.
- Note that the Form 6-K identifies InterCure as filing annual reports on Form 20-F.
- The filing is administrative and does not contain current financial results.